RNA Targeting Small Molecules Therapeutics Global Market Opportunities And Strategies To 2033
Including: 1) By Product: Antisense Oligonucleotides (ASOS); Small Interfering RNA (SIRNA)2) By Therapeutic Indication: Musculoskeletal Disorder; Neurodegenerative Diseases; Cardiovascular Disease; Genito-Urinary; Therapeutic Indications3) By End User: Hospitals; Research Laboratories; Pharmaceutical And Biotechnology CompaniesCovering: Ionis Pharmaceuticals; Alnylam Pharmaceuticals; Sarepta Therapeutics; Jazz Pharmaceuticals; Novartis
RNA Targeting Small Molecules Therapeutics Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global RNA targeting small molecules therapeutics market as it emerges from the COVID-19 shut down.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.
Where is the largest and fastest-growing market for RNA targeting small molecules therapeutics? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The RNA targeting small molecules therapeutics market global report from The Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s history and forecasts market growth by geography. It places the market within the context of the wider RNA targeting small molecules therapeutics market; and compares it with other markets.
The report covers the following chapters
- Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by type, by therapeutic indication and by end-user.
- Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
- Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the RNA targeting small molecules therapeutics market.
- Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
- Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
- Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by type, by therapeutic indication and by end-user in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
- Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
- Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
- Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
- Competitive Dashboard- Briefs on competitive dashboard of major players.
- Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
- Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
- Conclusions And Recommendations- This section includes recommendations for RNA targeting small molecules therapeutics providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
- Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
1) By Product: Antisense Oligonucleotides (ASOs); Small Interfering RNA (siRNA)
2) By Therapeutic Indication: Musculoskeletal Disorder; Neurodegenerative Diseases; Cardiovascular Disease; Genito-Urinary; Therapeutic Indications
3) By End User: Hospitals; Research Laboratories; Pharmaceutical and Biotechnology Companies; Other End-Users
Companies Mentioned: Ionis Pharmaceuticals; Alnylam Pharmaceuticals; Sarepta Therapeutics; Jazz Pharmaceuticals; Novartis
Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time-series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; RNA targeting small molecules therapeutics indicators comparison.
Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- 1 Executive Summary
- 1.1 RNA Targeting Small Molecule Therapeutics – Market Attractiveness And Macro economic Landscape
- 2 Table Of Contents
- 3 List Of Tables
- 4 List Of Figures
- 5 Report Structure
- 6 Market Characteristics
- 6.1 General Market Definition
- 6.2 Summary
- 6.3 RNA Targeting Small Molecules Therapeutics Market Definition And Segmentations
- 6.4 Market Segmentation By Product
- 6.4.1 Antisense Oligonucleotides (ASOs)
- 6.4.2 siRNA
- 6.5 Market Segmentation By Therapeutic Indication
- 6.5.1 Musculoskeletal Disorder
- 6.5.2 Neurodegenerative Diseases
- 6.5.3 Cardiovascular disease
- 6.5.4 Genito-Urinary
- 6.5.5 Other Therapeutic Indications
- 6.6 Market Segmentation By End-User
- 6.6.1 Hospitals
- 6.6.2 Research Laboratories
- 6.6.3 Pharmaceutical And Biotechnology Companies
- 6.6.4 Other End-Users
- 7 Major Market Trends
- 7.1 Strategic Collaboration Fueling RNA Targeting Small Molecules Therapeutics
- 7.2 Key Players Embrace Startup Solutions In RNA Targeting Small Molecules Therapeutics
- 7.3 Use Of Artificial Intelligence (AI) To Enhance Efficiency Of RNA Targeting Small Molecules During Drug Discovery
- 7.4 Partnerships Driving Innovation In RNA Targeting Small Molecules Therapeutics
- 7.5 Focus On Advancement In RNA Degrader Therapeutics Targeting For Various Medical Domains
- 7.6 Increased Focus On mRNA Small Molecule Drug Discovery
- 7.7 Development Of RNA Modulatory Drugs For Treating Neurological Diseases
- 8 RNA Targeting Small Molecules Therapeutics Market - Macro Economic Scenario
- 8.1 COVID-19 Impact On The RNA Targeting Small Molecules Therapeutics Market
- 8.2 Impact Of The War In Ukraine On The RNA Targeting Small Molecules Therapeutics Market
- 8.3 Impact Of High Inflation On The RNA Targeting Small Molecules Therapeutics Market
- 9 Global Market Size and Growth
- 9.1 Market Size
- 9.2 Historic Market Growth, 2018 – 2023, Value ($ Million)
- 9.2.1 Market Drivers 2018 – 2023
- 9.2.2 Market Restraints 2018 – 2023
- 9.3 Forecast Market Growth, 2023 – 2028, 2033F Value ($ Million)
- 9.3.1 Market Drivers 2023 – 2028
- 9.3.2 Market Restraints 2023 – 2028
- 10 Global RNA Targeting Small Molecules Therapeutics Market Segmentation
- 10.1 Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 10.2 Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 10.3 Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 11 RNA Targeting Small Molecules Therapeutics Market, Regional and Country Analysis
- 11.1 Global RNA Targeting Small Molecules Therapeutics Market, By Region, Historic and Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 11.2 Global RNA Targeting Small Molecules Therapeutics Market, By Country, Historic and Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 12 Asia-Pacific Market
- 12.1 Summary
- 12.1.1 Market Overview
- 12.1.2 Region Information
- 12.1.3 Market Information
- 12.1.4 Background Information
- 12.1.5 Government Initiatives
- 12.1.6 Regulations
- 12.1.7 Regulatory Bodies
- 12.1.8 Major Associations
- 12.1.9 Taxes Levied
- 12.1.10 Corporate Tax Structure
- 12.1.11 Investments
- 12.1.12 Major Companies
- 12.2 Asia-Pacific RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 12.3 Asia-Pacific RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 12.4 Asia-Pacific RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 12.5 Asia-Pacific RNA targeting Small Molecules Therapeutics Market: Country Analysis
- 12.6 China Market
- 12.7 Summary
- 12.7.1 Market Overview
- 12.7.2 Country Information
- 12.7.3 Market Information
- 12.7.4 Background Information
- 12.7.5 Government Initiatives
- 12.7.6 Regulations
- 12.7.7 Regulatory Bodies
- 12.7.8 Major Associations
- 12.7.9 Taxes Levied
- 12.7.10 Corporate Tax Structure
- 12.7.11 Investments
- 12.7.12 Major Companies
- 12.8 China RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 12.9 China RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 12.10 China RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 12.11 India Market
- 12.12 India RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 12.13 India RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 12.14 India RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 12.15 Japan Market
- 12.16 Japan RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 12.17 Japan RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 12.18 Japan RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 12.19 Australia Market
- 12.20 Australia RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 12.21 Australia RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 12.22 Australia RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 12.23 Indonesia Market
- 12.24 Indonesia RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 12.25 Indonesia RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 12.26 Indonesia RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 12.27 South Korea Market
- 12.28 South Korea RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 12.29 South Korea RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 12.30 South Korea RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 13 Western Europe Market
- 13.1 Summary
- 13.1.1 Market Overview
- 13.1.2 Region Information
- 13.1.3 Market Information
- 13.1.4 Background Information
- 13.1.5 Government Initiatives
- 13.1.6 Regulations
- 13.1.7 Regulatory Bodies
- 13.1.8 Major Associations
- 13.1.9 Taxes Levied
- 13.1.10 Corporate Tax Structure
- 13.1.11 Investments
- 13.1.12 Major Companies
- 13.2 Western Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 13.3 Western Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 13.4 Western Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 13.5 Western Europe RNA Targeting Small Molecules Therapeutics Market: Country Analysis
- 13.6 UK Market
- 13.7 UK RNA Targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 13.8 UK RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 13.9 UK RNA Targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 13.10 Germany Market
- 13.11 Germany RNA Targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 13.12 Germany RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 13.13 Germany RNA Targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 13.14 France Market
- 13.15 France RNA Targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 13.16 France RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 13.17 France RNA Targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 13.18 Italy Market
- 13.19 Italy RNA Targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 13.20 Italy RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 13.21 Italy RNA Targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 13.22 Spain Market
- 13.23 Spain RNA Targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 13.24 Spain RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 13.25 Spain RNA Targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 14 Eastern Europe Market
- 14.1 Summary
- 14.1.1 Market Overview
- 14.1.2 Region Information
- 14.1.3 Market Information
- 14.1.4 Background Information
- 14.1.5 Government Initiatives
- 14.1.6 Regulations
- 14.1.7 Regulatory Bodies
- 14.1.8 Major Associations
- 14.1.9 Taxes Levied
- 14.1.10 Corporate Tax Structure
- 14.1.11 Major Companies
- 14.2 Eastern Europe RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 14.3 Eastern Europe RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 14.4 Eastern Europe RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 14.5 Eastern Europe RNA targeting Small Molecules Therapeutics Market: Country Analysis
- 14.6 Russia Market
- 14.7 Russia RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 14.8 Russia RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 14.9 Russia RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 15 North America Market
- 15.1 Summary
- 15.1.1 Market Overview
- 15.1.2 Region Information
- 15.1.3 Market Information
- 15.1.4 Background Information
- 15.1.5 Government Initiatives
- 15.1.6 Regulations
- 15.1.7 Regulatory Bodies
- 15.1.8 Major Associations
- 15.1.9 Taxes Levied
- 15.1.10 Corporate Tax Structure
- 15.1.11 Investments
- 15.1.12 Major Companies
- 15.2 North America RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 15.3 North America RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 15.4 North America RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 15.5 North America RNA targeting Small Molecules Therapeutics Market: Country Analysis
- 15.6 USA Market
- 15.7 Summary
- 15.7.1 Market Overview
- 15.7.2 Country Information
- 15.7.3 Market Information
- 15.7.4 Background Information
- 15.7.5 Government Initiatives
- 15.7.6 Regulations
- 15.7.7 Regulatory Bodies
- 15.7.8 Major Associations
- 15.7.9 Taxes Levied
- 15.7.10 Corporate Tax Structure
- 15.7.11 Investments
- 15.7.12 Major Companies
- 15.8 USA RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 15.9 USA RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 15.10 USA RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 15.11 Canada Market
- 15.12 Canada RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 15.13 Canada RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 15.14 Canada RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 16 South America Market
- 16.1 Summary
- 16.1.1 Market Overview
- 16.1.2 Region Information
- 16.1.3 Market Information
- 16.1.4 Background Information
- 16.1.5 Government Initiatives
- 16.1.6 Regulations
- 16.1.7 Regulatory Bodies
- 16.1.8 Major Associations
- 16.1.9 Taxes Levied
- 16.1.10 Corporate Tax Structure
- 16.1.11 Investments
- 16.1.12 Major Companies
- 16.2 South America RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 16.3 South America RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 16.4 South America RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 16.5 South America RNA targeting Small Molecules Therapeutics Market: Country Analysis
- 16.6 Brazil Market
- 16.7 Brazil RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 16.8 Brazil RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 16.9 Brazil RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 17 Middle East Market
- 17.1 Summary
- 17.1.1 Market Overview
- 17.1.2 Region Information
- 17.1.3 Market Information
- 17.1.4 Background Information
- 17.1.5 Government Initiatives
- 17.1.6 Regulations
- 17.1.7 Regulatory Bodies
- 17.1.8 Major Associations
- 17.1.9 Taxes Levied
- 17.1.10 Corporate Tax Structure
- 17.1.11 Investments
- 17.1.12 Major Companies
- 17.2 Middle East RNA Targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 17.3 Middle East RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 17.4 Middle East RNA Targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 18 Africa Market
- 18.1 Summary
- 18.2 Market Overview
- 18.2.1 Region Information
- 18.2.2 Market Information
- 18.2.3 Background Information
- 18.2.4 Government Initiatives
- 18.2.5 Regulations
- 18.2.6 Regulatory Bodies
- 18.2.7 Major Associations
- 18.2.8 Taxes Levied
- 18.2.9 Corporate Tax Structure
- 18.2.10 Major Companies
- 18.3 Africa RNA Targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 18.4 Africa RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 18.5 Africa RNA Targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)
- 19 Competitive Landscape And Company Profiles
- 19.1 Company Profiles
- 19.2 Ionis Pharmaceuticals
- 19.2.1 Company Overview
- 19.2.2 Products And Services
- 19.2.3 Business Strategy
- 19.2.4 Financial performance
- 19.3 Alnylam Pharmaceuticals
- 19.3.1 Company Overview
- 19.3.2 Products And Services
- 19.3.3 Business Strategy
- 19.3.4 Financial performance
- 19.4 Sarepta Therapeutics
- 19.4.1 Company Overview
- 19.4.2 Products And Services
- 19.4.3 Business Strategy
- 19.4.4 Financial performance
- 19.5 Jazz Pharmaceuticals
- 19.5.1 Company Overview
- 19.5.2 Products And Services
- 19.5.3 Financial performance
- 19.6 Novartis
- 19.6.1 Company Overview
- 19.6.2 Products And Services
- 19.6.3 Business Strategy
- 19.6.4 Financial performance
- 20 RNA Targeting Small Molecules Therapeutics Market Other Major And Innovative Companies
- 20.1 NS Pharma
- 20.1.1 Company Overview
- 20.1.2 Products And Services
- 20.2 Arrakis Therapeutics
- 20.2.1 Company Overview
- 20.2.2 Products And Services
- 20.3 PTC Therapeutics
- 20.3.1 Company Overview
- 20.3.2 Products And Services
- 20.4 Anima Biotech Inc.
- 20.4.1 Company Overview
- 20.4.2 Products And Services
- 20.5 Ribometrix
- 20.5.1 Company Overview
- 20.5.2 Products And Services
- 20.6 Skyhawk Therapeutics Inc.
- 20.6.1 Company Overview
- 20.6.2 Products And Services
- 20.7 STORM Therapeutics Ltd.
- 20.7.1 Company Overview
- 20.7.2 Products And Services
- 20.8 Accent Therapeutics
- 20.8.1 Company Overview
- 20.8.2 Products And Services
- 20.9 Promega Corporation
- 20.9.1 Company Overview
- 20.9.2 Products And Services
- 20.10 Bayer AG
- 20.10.1 Company Overview
- 20.10.2 Products And Services
- 20.11 Arrowhead Pharmaceuticals Inc.
- 20.11.1 Company Overview
- 20.11.2 Products And Services
- 20.12 Abivax SA
- 20.12.1 Company Overview
- 20.12.2 Products And Services
- 20.13 AC Immune SA
- 20.13.1 Company Overview
- 20.13.2 Products And Services
- 20.14 Remix Therapeutics
- 20.14.1 Company Overview
- 20.14.2 Products And Services
- 20.15 858 Therapeutics
- 20.15.1 Company Overview
- 20.15.2 Products And Services
- 21 Competitive Benchmarking
- 22 Competitive Dashboard
- 23 Key Mergers And Acquisitions
- 23.1 Novo Nordisk Acquire DiceRNA Pharmaceuticals
- 23.2 Sanofi's Acquired Translate Bio
- 24 Opportunities And Strategies
- 24.1 Global RNA Targeting Small Molecules Therapeutics Market In 2028 – Countries Type Most New Opportunities
- 24.2 Global RNA Targeting Small Molecules Therapeutics Market In 2028 – Segments Type Most New Opportunities
- 24.3 Global RNA Targeting Small Molecules Therapeutics Market In 2028 – Growth Strategies
- 24.3.1 Market Trend Based Strategies
- 24.3.2 Competitor Strategies
- 25 RNA Targeting Small Molecules Therapeutics Market, Conclusions And Recommendations
- 25.1 Conclusions
- 25.2 Recommendations
- 25.2.1 Product
- 25.2.2 Place
- 25.2.3 Price
- 25.2.4 Promotion
- 25.2.5 People
- 26 Appendix
- 26.1 Geographies Covered
- 26.2 Market Data Sources
- 26.3 Research Methodology
- 26.4 Currencies
- 26.5 The Business Research Company
- 26.6 Copyright and Disclaimer
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook